查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1871287

血管移植市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）

Vascular Graft Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球血管移植市场价值为 36 亿美元，预计到 2034 年将以 6.9% 的复合年增长率增长至 73 亿美元。

血管移植市场 - IMG1

心血管疾病盛行率的上升、技术创新、末期肾病（ESRD）发生率的增加以及全球外科手术量的增加，共同推动了血管移植市场的扩张。血管移植是一种用于替代、修復或绕过受损或病变血管的医疗器械，旨在恢復正常的血流。这些移植材料是由合成材料、生物组织或二者的混合物製成。它们广泛用于治疗心血管疾病、动脉瘤和血液透析通路。近年来，生物工程移植、肝素涂层ePTFE移植和混合材料等技术的进步，提高了移植材料的生物相容性，降低了血栓形成风险，并改善了长期通畅率。此外，微创和血管内手术的日益普及、组织工程和可生物降解移植材料的使用增加、药物洗脱和涂层移植材料的推广应用以及新兴市场的扩张，也共同推动了血管移植行业的成长。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 36亿美元
预测值 73亿美元
复合年增长率 6.9%

2024年，聚酯移植物市占率达62.3%。聚酯移植物因其耐用性、优异的生物相容性以及在血管修復和搭桥手术中经证实的长期通畅率而备受青睐。其丰富的临床应用历史和在主动脉及週边血管搭桥手术中的稳定表现赢得了外科医生的高度信赖，使其成为血管手术中的常用材料。

预计2034年，血液透析通路市场将以6.3%的复合年增长率成长。末期肾病（ESRD）病例的增加以及需要长期血液透析的患者数量的增长，推动了对血管移植的需求。移植血管设计的创新，例如提高通畅率和降低感染风险，进一步促进了该领域的成长。

2024年，北美血管移植市占率达32.2%。冠状动脉疾病、週边动脉疾病和主动脉瘤的高发生率是该地区强劲需求的主要原因。拥有完善的医院体系，配备专业的血管外科中心，并拥有先进的外科技术，这为开放式手术和腔内血管移植手术的开展提供了支持。

全球血管移植物市场的主要参与者包括库克医疗（Cook Medical）、戈尔（Gore）、泰尔茂（Terumo）、美敦力（Medtronic）、贝朗（B. Braun）、美瑞医疗系统（Merit Medical Systems）、乐迈特（LeMaitre）、雅培（Abbott）、Endologix、血管移植物解决方案Solutions）、微创医疗器材（MicroPort）、Artivion、BD（贝克顿·迪金森公司）、Getinge 和 Cordis。血管移植物市场的各公司正采取多种策略来巩固其市场地位。他们大力投资研发，以开发具有更高通畅率、生物相容性和更低併发症风险的创新移植物。策略性併购和合作有助于拓展产品组合和区域覆盖范围。许多公司专注于技术进步，包括药物洗脱移植物、生物工程移植物和混合移植物。行销活动、外科医生教育计画以及与医院的紧密合作有助于提升品牌知名度和信任度。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

  • 产业生态系分析
  • 产业影响因素
    • 成长驱动因素
      • 全球慢性病数量不断增加
      • 发展中经济体末期肾病患者数量不断增加
      • 已开发国家的技术进步
      • 器官移植数量上升
    • 产业陷阱与挑战
      • 发展中国家缺乏熟练人员
      • 移植感染和血栓形成的风险
    • 市场机会
      • 生物可吸收和混合移植物的研究进展
      • 3D列印技术在移植片开发的应用日益广泛
  • 成长潜力分析
  • 报销方案
  • 监管环境
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
  • 技术格局
    • 当前技术趋势
    • 新兴技术
  • 消费者分析
  • 价值链分析
  • 未来市场趋势
  • 关键投资和扩张趋势
  • 移植类型概述
  • 接枝材料和涂层的创新
  • 波特的分析
  • PESTEL 分析
  • 差距分析

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
    • 全球的
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
  • 竞争定位矩阵
  • 主要市场参与者的竞争分析
  • 关键进展
    • 併购
    • 合作伙伴关係与合作
    • 新原料上市
    • 扩张计划

第五章：市场估算与预测：依原料划分，2021-2034年

  • 主要趋势
  • 聚酯接枝
  • ePTFE移植物
  • 生物合成接枝
  • 聚氨酯接枝

第六章：市场估算与预测：依应用领域划分，2021-2034年

  • 主要趋势
  • 血管内动脉瘤修復术
    • 腹主动脉瘤修復
    • 胸主动脉瘤修復术
  • 血液透析通路
  • 週边血管修復

第七章：市场估算与预测：依最终用途划分，2021-2034年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 其他最终用途

第八章：市场估算与预测：依地区划分，2021-2034年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第九章：公司简介

  • Abbott
  • Artivion
  • B. Braun
  • BD (Becton, Dickinson & Company)
  • Cook Medical
  • Cordis
  • Endologix
  • Getinge
  • Gore
  • LeMaitre
  • Medtronic
  • Merit Medical Systems
  • MicroPort
  • Terumo
  • Vascular Graft Solutions
简介目录
Product Code: 2492

The Global Vascular Graft Market was valued at USD 3.6 billion in 2024 and is estimated to grow at a CAGR of 6.9% to reach USD 7.3 billion by 2034.

Vascular Graft Market - IMG1

The market expansion is driven by the rising prevalence of cardiovascular disorders, technological innovations, and the growing incidence of end-stage renal disease (ESRD), along with an increase in surgical interventions worldwide. Vascular grafts are medical devices designed to replace, repair, or bypass damaged or diseased blood vessels, restoring normal blood flow. These grafts are manufactured from synthetic materials, biological tissues, or a hybrid of both. They are widely used in treatments for cardiovascular conditions, aneurysms, and hemodialysis access. Recent advancements, such as bioengineered grafts, heparin-coated ePTFE grafts, and hybrid materials, enhance compatibility, reduce thrombosis risk, and improve long-term patency. The market is also benefiting from the growing preference for minimally invasive and endovascular procedures, increasing use of tissue-engineered and biodegradable grafts, adoption of drug-eluting and coated grafts, and expansion in emerging markets, collectively propelling industry growth.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$3.6 Billion
Forecast Value$7.3 Billion
CAGR6.9%

The polyester grafts segment held a 62.3% share in 2024. Polyester grafts are preferred for their durability, excellent biocompatibility, and proven long-term patency in vascular repair and bypass procedures. Their extensive clinical history and consistent performance in aortic and peripheral bypass surgeries have earned them high trust among surgeons, making them a staple in vascular procedures.

The hemodialysis access segment is expected to grow at a CAGR of 6.3% through 2034. Rising cases of ESRD and an increasing number of patients requiring long-term hemodialysis are driving demand for vascular grafts. Innovations in graft design that improve patency and minimize infection risks further support growth in this segment.

North America Vascular Graft Market held a 32.2% share in 2024. High rates of coronary artery disease, peripheral artery disease, and aortic aneurysms contribute to the region's strong demand. Well-established hospitals with specialized vascular surgery centers and access to advanced surgical technologies support the adoption of both open and endovascular graft procedures.

Key players in the Global Vascular Graft Market include Cook Medical, Gore, Terumo, Medtronic, B. Braun, Merit Medical Systems, LeMaitre, Abbott, Endologix, Vascular Graft Solutions, MicroPort, Artivion, BD (Becton, Dickinson & Company), Getinge, and Cordis. Companies in the Vascular Graft Market are adopting multiple strategies to strengthen their market position. They are heavily investing in research and development to create innovative grafts with improved patency, biocompatibility, and reduced complication risks. Strategic mergers, acquisitions, and partnerships help expand product portfolios and regional reach. Many firms focus on technological advancements, including drug-eluting, bioengineered, and hybrid grafts. Marketing campaigns, surgeon education programs, and strong hospital collaborations improve brand recognition and trust.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Raw Material trends
    • 2.2.3 Application trends
    • 2.2.4 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing number chronic diseases worldwide
      • 3.2.1.2 Growing number of end-stage renal disorders in developing economies
      • 3.2.1.3 Technological advancements in developed countries
      • 3.2.1.4 Rise in organ transplantation
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Lack of skilled personnel in developing countries
      • 3.2.2.2 Risk of graft infection and thrombosis
    • 3.2.3 Market opportunities
      • 3.2.3.1 Development of bioresorbable and hybrid grafts
      • 3.2.3.2 Rising adoption of 3D printing in graft development
  • 3.3 Growth potential analysis
  • 3.4 Reimbursement scenario
  • 3.5 Regulatory landscape
    • 3.5.1 North America
    • 3.5.2 Europe
    • 3.5.3 Asia Pacific
    • 3.5.4 LAMEA
  • 3.6 Technology landscape
    • 3.6.1 Current technological trends
    • 3.6.2 Emerging technologies
  • 3.7 Consumer analysis
  • 3.8 Value chain analysis
  • 3.9 Future market trends
  • 3.10 Key investment and expansion trends
  • 3.11 Overview of graft types
  • 3.12 Innovations in graft materials and coatings
  • 3.13 Porter's analysis
  • 3.14 PESTEL analysis
  • 3.15 Gap analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
    • 4.3.5 LAMEA
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New raw material launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Raw Material, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Polyester grafts
  • 5.3 ePTFE grafts
  • 5.4 Biosynthetic grafts
  • 5.5 Polyurethane grafts

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Endovascular aneurysm repair
    • 6.2.1 Abdominal aortic aneurysm repair
    • 6.2.2 Thoracic aortic aneurysm repair
  • 6.3 Hemodialysis access
  • 6.4 Peripheral vascular repair

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott
  • 9.2 Artivion
  • 9.3 B. Braun
  • 9.4 BD (Becton, Dickinson & Company)
  • 9.5 Cook Medical
  • 9.6 Cordis
  • 9.7 Endologix
  • 9.8 Getinge
  • 9.9 Gore
  • 9.10 LeMaitre
  • 9.11 Medtronic
  • 9.12 Merit Medical Systems
  • 9.13 MicroPort
  • 9.14 Terumo
  • 9.15 Vascular Graft Solutions